Revvity Debuts Inaugural ESG Report

Revvity, Inc. (NYSE: RVTY) today unveils its inaugural 2023 Environmental, Social and Governance (ESG) Report. An in-depth overview of the Companyโ€™s ESG strategy, initiatives and performance, the report showcases the Companyโ€™s deepening commitment to driving more sustainable solutions, along with a culture of transparency, empowerment and inclusivity.

โ€œRevvityโ€™s ESG program and goals boldly represent what weโ€™re all about โ€“ ensuring that every day we are working to be better by not only helping advance science, but also doing so in a way that improves lives and the environment,โ€ said Prahlad Singh, president and chief executive officer at Revvity. โ€œWith Revvity still in its infancy, itโ€™s important we establish ambitious, yet realistic, ESG goals that will guide our progress and ensure accountability as we look to drive a positive impact on the world.โ€

Key goals highlighted in the report include:

  • Achieving a 50% reduction of the Companyโ€™s Scope 1 and 2 greenhouse gas emissions by 2033
  • Reaching net carbon neutrality by 2040
  • Achieving 40% non-hazardous waste landfill diversion by 2027
  • Maintaining greater than 40% female representation in leadership positions
  • Achieving greater than 75% employee satisfaction
  • Further evaluating and implementing gender pay equality commitments over the next 12 months

To learn more about Revvityโ€™s ESG commitments and progress visit esg.revvity.com.

About Revvity

At Revvity, โ€œimpossibleโ€ is inspiration, and โ€œcanโ€™t be doneโ€ is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing whatโ€™s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more.

With 2022 revenue of more than $3 billion and over 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 190 countries.

Stay updated by following our Newsroom, LinkedIn, X, YouTube, Facebook and Instagram.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  228.75
-0.78 (-0.34%)
AAPL  277.37
-1.41 (-0.51%)
AMD  220.06
+2.09 (0.96%)
BAC  53.83
-0.12 (-0.22%)
GOOG  317.66
-4.43 (-1.38%)
META  669.29
-4.12 (-0.61%)
MSFT  489.58
+6.42 (1.33%)
NVDA  183.78
+1.37 (0.75%)
ORCL  220.24
+2.66 (1.22%)
TSLA  442.96
-12.04 (-2.65%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Gift this article